These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3971306)

  • 1. Association of chronic cystic mastopathy, xeromammographic patterns, and cancer.
    Spratt JS; Alagia DP; Greenberg RA; Kuhns JG; Buchanan JB; Warren JB; Polk HC
    Cancer; 1985 Mar; 55(6):1372-5. PubMed ID: 3971306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinicopathologic correlation of mammographic parenchymal patterns and associated risk factors for human mammary carcinoma.
    Bland KI; Kuhns JG; Buchanan JB; Dwyer PA; Heuser LF; O'Connor CA; Gray LA; Polk HC
    Ann Surg; 1982 May; 195(5):582-94. PubMed ID: 7073355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xeromammographic diagnosis of carcinoma of the breast in office practice.
    Burhenne LW; Longley JD; Burhenne HJ
    Surg Gynecol Obstet; 1987 May; 164(5):452-6. PubMed ID: 3576422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic parenchymal patterns and risk of breast cancer in postmenopausal women.
    Horwitz RI; Lamas AM; Peck D
    Am J Med; 1984 Oct; 77(4):621-4. PubMed ID: 6486138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fine-needle biopsy of the breast in the material of Gynecology and Obstetrics Hospital in Walbrzych].
    Suchocki S; Łuczyński K; Szymczyk A; Piec P
    Ginekol Pol; 2002 Nov; 73(11):1113-6. PubMed ID: 12722408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single view negative mode xeromammography: an approach to reduce radiation exposure in breast cancer screening.
    Buchanan JB; Jager RM
    Radiology; 1977 Apr; 123(1):63-8. PubMed ID: 847175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer prediction and the Wolfe classification of mammograms.
    Carlile T; Kopecky KJ; Thompson DJ; Whitehead JR; Gilbert FI; Present AJ; Threatt BA; Krook P; Hadaway E
    JAMA; 1985 Aug 23-30; 254(8):1050-3. PubMed ID: 4021043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign breast disease and the risk of breast cancer in the next 15 years.
    Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [When are recommended breast biopsies carried out, and what information does the physician responsible for mammography receive? Experiences with 317 breast biopsy in a regional quality assurance project for screening mammography].
    Meyer JM; Swart E; Dierks ML; Robra BP
    Pathologe; 1997 Jan; 18(1):60-6. PubMed ID: 9157406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeromammographic screening: is it helping?
    Hatton PD; Harford FJ; Sheppard JR
    South Med J; 1984 Jul; 77(7):857-9. PubMed ID: 6740354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinaemia and breast disease as evaluated by xeromammography.
    Calhaz-Jorge C; Cunha C; Nunes MC; Sobrinho LG
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):347-50. PubMed ID: 7113603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic microcalcification and parenchymal patterns as indicators of histologic "high-risk" benign breast disease.
    Bartow SA; Pathak DR; Mettler FA
    Cancer; 1990 Oct; 66(8):1721-5. PubMed ID: 2208027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cystic masthopathya: twenty-five years experience.
    Papolczay A; Vörös A; Bihari I
    Acta Chir Acad Sci Hung; 1978; 19(4):349-56. PubMed ID: 757916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of breast cancer subsequent to proven gross cystic disease.
    Ciatto S; Biggeri A; Rosselli Del Turco M; Bartoli D; Iossa A
    Eur J Cancer; 1990; 26(5):555-7. PubMed ID: 2144739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy.
    Hou Y; Chaudhary S; Gao FF; Li Z
    Ann Diagn Pathol; 2016 Oct; 24():4-6. PubMed ID: 27649945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.